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Objective: To describe the characteristics of recurrent pelvic organ prolapse (POP). Methods: A convenience
sample of patients presenting with recurrent POP symptoms between October 2007 and February 2010
completed questionnaires. The survey focused on timing of recurrence(s), symptoms, and demographics.
Results: Ninety-seven women completed questionnaires. Thirty-four (35.1%) had undergone multiple prior
treatments. Overall, 23 of 76 (30.3%) women had not informed their surgeon of the recurrence. Twenty-
seven of 59 (45.8%) women reported that their symptoms were the same as before treatment, whereas 23
of 59 (39.0%) reported more severe symptoms. POP was considered to be persistent if symptoms returned
within 3 months, and recurrent if symptom relief exceeded 3 months. After primary surgery, 28 of 79
(35.4%) cases were considered to be persistent, whereas 51 (64.6%) cases were recurrent. Similar percentages
were seen after second and third treatments. Conclusion: Overall, 35% of participants experienced early return
of symptoms. Almost one-third of participants had not informed their surgeon of the recurrence, indicating
that there may not be an accurate self-assessment of outcome in the absence of careful follow-up.
© 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Symptomatic pelvic organ prolapse (POP), which is defined as the
downward descent of female pelvic organs, is estimated to affect 2.9%
of women in the USA [1]. One in 10 women in the USA chooses surgi-
cal management for either urinary incontinence or POP [2], which in
some cases is persistent or recurrent. Retrospective and prospective
observational studies have cited overall recurrence rates ranging
from 13% to 58% [3–5]. Given these high rates, there is surprisingly
limited information in the literature regarding the natural history
and timing of recurrent POP.
The aim of the present study was to determine the following
among women with recurrent prolapse confirmed on physical
examination: how many had not reported the return of symptoms
to their original surgeon; whether the symptoms they attributed to
recurrent prolapse were similar in severity to the symptoms that
were present preoperatively; and the length of time prior to them
becoming aware of prolapse recurrence.Dr., Women's Hospital L4100,
6; fax: +1 734 647 9272.
Lancey).
eration of Gynecology and Obstetrics. P2. Materials and methods
The present convenience sample study was conducted at the uro-
gynecology clinic of the University of Michigan, Ann Arbor, USA,
which is a tertiary care center. Patients presenting to the urogynecol-
ogy clinic for recurrent POP were recruited after identification in 1 of
2 ways. First, women presenting with confirmed recurrent prolapse
(defined as any compartment at or below the hymen on physical ex-
amination) between February 1, 2008, and February 28, 2010, were
identified at the time of initial clinical evaluation, and if research per-
sonnel were available a questionnaire was administered (Supplemen-
tary Material S1). Second, because convenience sampling was used
and research personnel were not always available, surgical records
were then retrospectively reviewed for women who underwent sur-
gery for recurrent prolapse at the study institution between October
1, 2007, and February 28, 2010, who had not already completed the
questionnaire (Supplementary Material S2). Inclusion criteria re-
quired that women had at least 1 prior episode of POP managed
with operative treatment and confirmed recurrence of POP on phys-
ical examination. The recurrent POP at the time of presentation was
regarded as the index prolapse. The study was approved by the Insti-
tutional Review Board for Human Subject Research (HUM00017850)
of the University of Michigan. The completion and return of the ques-
tionnaire from patients implied consent.ublished by Elsevier Ireland Ltd. All rights reserved.
Table 1
Participant demographics (n=97).a
Characteristic Value
Age at presentation, y 62.6±9.8
Age at initial occurrence, y 50.7±14.4
BMI 29.7±18.0
Parity 2.9±1.3
Hysterectomy
No 4 (4.1)
Yes 93 (95.9)
Prolapse 62 (67.0)
Other 31 (33.0)
Menopausal (n=96)
No 8 (8.3)
Yes 88 (91.7)
Race
White 93 (95.9)
African American 3 (3.1)
Asian 1 (1.0)
Prolapseb 97 (100.0)
Total number of previous surgeries
1 63 (64.9)
2 25 (25.8)
3 6 (6.2)
≥4 3 (3.1)
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by the
square of height in meters).
a Values are given as mean±SD or number (percentage).
b Confirmed by physician at physical examination.
Fig. 1. Histograms of compartment Pelvic Organ Prolapse Quantification System values.
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the index POP, as well as reflect on past recurrences. The survey was
generated by several of the authors—using questions that were typi-
cally captured on initial evaluation—and focused on information re-
lated to timing of recurrence(s), symptoms of index POP recurrence,
and demographic characteristics (body mass index, parity, hysterec-
tomy, and menopausal status).
The initial questionnaire was screened among a pilot group of
women, then updated to enhance clarity based on their feedback. Fur-
ther characterization of POP and the timeline of recurrence was
achieved via review of physician notes and electronic medical records
by research assistants. When available, POP Quantification System
(POP-Q) values were used to define prolapse within the anterior
(Ba), posterior (Bp), and apical (C) compartments. Prolapse was de-
fined as a POP-Q value of greater than or equal to 0. The timeline of
recurrence was established from the patient survey and was based
on the answer to the following question: “Did you have any period
of time after your most recent failed surgery for prolapse during
which you were not bothered by the bulge? If yes, for how long?” Re-
current prolapse was defined subjectively by the patient for all recur-
rences and was objectively confirmed for the index recurrence as
descent of any vaginal compartment below the hymen on clinical
examination.
Data were evaluated with SAS version 9.1 (SAS Institute, Cary, NC,
USA) using descriptive statistics, unpaired and paired t tests, and
McNemar test. Pb0.05 was considered to be statistically significant.
3. Results
In total, 106 questionnaires were completed and collected. Nine
were excluded because patient identity could not be confirmed in
order to perform chart substantiation of the data. Thus, 97 completed
questionnaires were available for analysis. Not all women answered
each question, however, so data are presented with the denominator
representing the number who answered a particular question. The
participating womenwere all parous, predominantly white, and post-
menopausal, with prior hysterectomy (two-thirds were for prolapse)
and confirmed prolapse on examination. Before presentation, all pa-
tients had undergone at least 1 surgical treatment for prolapse, and
34 (35.1%) had undergone multiple prior treatments (Table 1).
In total, 80 of 94 (85.1%) participants reported that they self-
discovered the index prolapse, whereas the remaining 14 (14.9%)
were diagnosed by a physician. Overall, 23 of 76 (30.3%) women
reported that they had not informed their previous surgeon of the re-
currence. At presentation to the study center, 90 (92.8%) patients had
a documented POP-Q score confirming at least 1 compartment pro-
lapse, as defined above. Of the participants with documented POP-Q
values, 55 of 89 (61.8%) had an anterior prolapse, 37 of 90 (41.1%)
had a posterior prolapse, and 30 of 90 (33.3%) had an apical prolapse
(Fig. 1). As determined by POP-Q values, 46 (51.1%) had 1, 27 (30.0%)
had 2, and 17 (18.9%) had 3 prolapsed compartments. The POP-Q
values between the patient- and the doctor-discovered populations
were not statistically different when comparing specific compart-
ments (Ba [P=0.205]; Bp [P=0.231]; and C [P=0.220]) or maximal
descent (P=0.970).
In addition to the symptoms due to the prolapse itself, other pelvic
floor symptoms at the index POP were described by 91 participants.
The most common non-prolapse symptoms associated with prolapse
return were incomplete emptying of bowel (n=51 [56.0%]), urinary
incontinence (n=49 [53.8%]), low back pain (n=45 [49.5%]), consti-
pation (n=38 [41.8%]), and dyspareunia (n=36 [39.6%]) (Fig. 2).
Overall, 47 of 89 (52.8%) participants reported that their index symp-
toms were consistent with symptoms they experienced with their
previous prolapse. Fifty-nine women reported on the severity of
their symptoms; 27 (45.8%) stated that they were the same as before
treatment and 23 (39.0%) stated that they were more severe.Participants were stratified as having persistent prolapse if return
of symptoms occurred within 3 months of previous surgery, and re-
current prolapse if relief of symptoms was present for at least
3 months after surgery. Fig. 3 shows the percentage of participants
in each category after each surgical treatment. Patient recall of
Fig. 2. Most commonly experienced symptoms of patients at presentation.
Table 2
Patient recall of symptom return and treatment timeline.
Surgery Return of symptoms, mo Interval to next surgery, mo
Primary
Mean±SD 45.1±86.9a 89.3±106.3d
Median (range) 6 (0–480)a 48 (2–555)d
Secondary
Mean±SD 24.5±36.8b 71.7±77.9e
Median (range) 6 (0–120)b 35 (4–341)e
Tertiary
Mean±SD 14.8±13.6c 29.9±25.2f
Median (range) 15 (0–36)c 23.5 (4–75)f
a n=79.
b n=24.
c n=6.
d n=97.
e n=31.
f n=8.
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(35.4%) women were categorized as having persistent prolapse and
51 (64.6%) had recurrent POP, with a mean 69.1 months of relief.
Similar percentages were seen for persistence versus recurrence
after second and third treatments. When evaluating first, second,
and third treatments, there was no significant difference in the pro-
portions of women who experienced return of symptoms within
3 months (P=0.980; McNemar test).
Table 2 shows mean time to return of symptoms and next surgical
treatment for the entire cohort (i.e. recurrent and persistent groups).
Although there seemed to be a trend toward shorter time intervals
with each successive treatment, paired t tests did not show significant
differences between the groups for return of symptoms (P=0.16 for
primary and secondary; P=0.13 for secondary and tertiary) or subse-
quent treatment (P=0.25 for primary and secondary; P=0.24 for
secondary and tertiary). Fig. 4 shows return of symptoms as a func-
tion of time, emphasizing the large proportion of patients with early
return of symptoms.4. Discussion
There are 3 key findings from the present study of women seeking
care for recurrent prolapse: regardless of the number of prior treat-
ment failures, symptoms returned within 3 months of the operation
in 35% of cases; almost one-third of patients reported that they had
not informed their previous surgeon of symptom recurrence; and
the majority of women felt that their symptoms were either the
same as or worse than before treatment. Although mean time to re-
turn of symptoms and time to next treatment seemed to decreaseFig. 3. Percentages of patients with return of symptoms within 3 months of treatment
(persistence group) and those who experienced more than 3 months of relief (recur-
rence group).with each successive operation, there was too much variability within
the sample size for these results to be statistically significant.
The timing of recurrent prolapse has been detailed in several
studies based on clinical examination at follow-up appointments,
intervals between treatments, and reoperation rates calculated
from records [5–7]. Price et al. [6] reported that more than half of pa-
tients undergoing their first reoperation for recurrent prolapse did
so in the first 3 years, and Fialkow et al. [7] reported a mean time
to reoperation of 4.15 years [7]. The present median of 4 years to
reoperation after primary surgical treatment is consistent with
these published data.
Timing of early recurrence is sparsely reported in the literature.
Based on reoperation rates, Clark et al. [4] plotted survival curves of
2 populations (first operation vs previous operative treatments) but
did not detail early recurrences. Price et al. [6] reported that the ma-
jority of their population experienced recurrence within 3 years [6];
however, the present study addressed the return of symptoms within
the first 3 months after surgery.
In the present study, therewere time differences between a patient's
perception of prolapse return and when treatment was sought for re-
current prolapse, indicating that the date a patient returns for re-
treatment or the date of reoperation may not be good surrogates for
documentingwhen prolapse actually returned. The study aimed to dis-
tinguish between persistence and recurrence of POP, using return of
symptoms as the marker. The early return of symptoms indicates
persistence of prolapse or failure of a previous operative approach
to achieve even short-term success, thus questioning the current
ability to address properly the initial problem causing POP.
At the study center, almost one-third of participants had not
reported the return of symptoms to their primary surgeon, indicat-
ing that surgeons may not know that such failures have occurred.
In addition to migration issues, the literature highlights many bar-
riers to seeking further treatment. Attitudes toward aging, inconti-
nence, treatment, and health professionals are all reasons for some
women not seeking further treatment [8]—often leaving the primary
surgeon unaware of any problems. Limited postoperative informa-
tion for the primary surgeon leads to less self-awareness of surgical
failure rates and is rarely discussed in the literature.
The most common symptoms reported by the study population
were incomplete emptying of bowel, urinary incontinence, low back
pain, constipation, and dyspareunia. Importantly, most participants
reported symptoms of similar or worse severity compared with
prior episodes of prolapse. Because there were no objective data re-
garding prior prolapse characteristics of patients, the reported data
could not be correlated with prolapse compartment or prolapse se-
verity. This is unfortunate because prolapse and its associated symp-
toms have been vigorously investigated in the literature, resulting in
contrasting evidence. Urinary and defecatory obstructive symptoms
Fig. 4. Frequency distribution of symptom return. Also shown is symptom return within the first year. In the year chart, values were rounded to the nearest integer. In the month
chart, they were placed in the interval they fell into (no rounding occurred).
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have even cited specific symptom correlations with prolapse severi-
ty [11,12]. In the study by Erekson et al. [12], themost commonly expe-
rienced symptomswere dyspareunia, incomplete voiding, constipation,
urinary frequency, and urgency. Other groups have shown that com-
mon symptoms of low back and groin pain are not associated with
prolapse [13,14] and that frequency and voiding difficulties, bowel
movements, and the need for splinting do not correlate with specific
compartments of prolapse [15].
There is a multitude of research on the risk factors associated with
POP and recurrent POP. It has been reported that previous reconstruc-
tive surgery is a risk factor for recurrence [4,16]; this information cor-
relates well with the trend in the present study that time to return of
symptoms and mean time between treatments decrease with each
successive operation (although the present data were not statistically
significant).
Although recall bias must be considered a constraint of the present
study, the results are still valuable because many clinical decisions are
based on patients' reported histories in conjunction with objective
physical findings. The retrospective nature of the study limited the op-
portunity to conduct survivability tests. In addition, objective POP-Q
data were not available for all previous failures, meaning that a com-
partment failure analysis could not be performed; this information
would be helpful and deserves further study. Finally, the present
study involved a convenience sample of a predominately white pop-
ulation (disqualifying any interracial comparisons) at a tertiary-care
referral center, so the generalizability of the results is limited. How-
ever, although the findings may not be applicable to the general pop-
ulation, they are still important in terms of the assessment of referral
clinic cohorts.
Despite the limitations, the present study indicates that—in the
absence of careful follow-up—surgeons may have inaccurate self-
assessments of success. It also highlights the high percentage of
early recurrence, thus indicating that current surgical techniques
do not properly address the causes of POP and providing momentum
to the quest for better understanding of the mechanisms of prolapse.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ijgo.2012.07.024.
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